Tumor metabolism atlas can help discover cancer mechanisms

An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.

NYC faculty discuss equity, community ownership

Faculty in Cornell’s Action Research Collaborative (ARC) joined New York City and State policymakers and community members for ARC’s second symposium on June 22. The annual symposium is an opportunity for researchers, policymakers and community stakeholders to share their knowledge and advance equity in areas like nutrition and health, housing and social services, and youth development. 

Around Cornell

Molecular signals key to malaria parasite’s development

New findings about a developmental step in the lifecycle of malaria parasites may help scientists develop new ways to prevent the disease from spreading.

2023 Johnson Summer Startup Accelerator names record cohort

The Samuel Curtis Johnson Graduate School of Management unveiled the diverse group of 25 startups that make up the 2023 Johnson Summer Startup Accelerator (JSSA), the program's largest cohort to date.

Around Cornell

Harlem youth lead projects that benefit their community

With a bit of funding, high school students not only helped their neighbors but also offered researchers insights into how young people think about their capacity to make a difference.

DNA shapes itself to execute new functions

DNA can mimic protein functions by folding into elaborate, three-dimensional structures, according to a study from researchers at Weill Cornell Medicine and the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Wildfire smoke downwind affects health, wealth and mortality

Smoke particulates from wildfires could lead to between 4,000 and 9,000 premature deaths and cost $36 to $82 billion per year in the U.S., according to research by Cornell and a university in China.

Federal program inadvertently promotes costlier drugs

A new study investigated whether the structure of the 340B Drug Pricing Program inhibits the use of biosimilar medications, which are medically equivalent but not identical to original biologic drugs due to production differences.

Biomedical engineering symposium showcases research, facilitates collaborations

The “Biomedical Engineering Symposium: Tools to Transform Discovery and Care,” brought together dozens of engineers, scientists and practitioners from across Cornell to share research and foster collaborations, with the goal of building the foundation for new, cutting-edge medical treatments and devices.

Around Cornell